Korean Journal of Head & Neck Oncology (대한두경부종양학회지)

The Korean Society for Head and Neck Oncology (대한두경부종양학회)
권호 표지

Therapeutic Effect of Oncolytic Herpes Simplex Virus on Induced Radioresistant Head and Neck Squamous Cell Carcinoma

방사선 치료에 내성이 유도된 두경부 편평세포암에 대한 종양살상 헤르페스 바이러스의 유전자 치료 효과

  • Kim, Se-Heon (Department of Otorhinolaryngology, Yonsei University College of Medicine) ;
  • Choi, Eun-Chang (Department of Otorhinolaryngology, Yonsei University College of Medicine) ;
  • Lee, Jin-Seok (Department of Otorhinolaryngology, Yonsei University College of Medicine) ;
  • Chun, Je-Young (Department of Otorhinolaryngology, Yonsei University College of Medicine) ;
  • Byun, Hyung-Kwon (Department of Otorhinolaryngology, Yonsei University College of Medicine) ;
  • Song, Ki-Jae (Department of Otorhinolaryngology, Yonsei University College of Medicine) ;
  • Kim, Kwang-Moon (Department of Otorhinolaryngology, Yonsei University College of Medicine)
  • 김세헌 (연세대학교 의과대학 이비인후과학교실) ;
  • 최은창 (연세대학교 의과대학 이비인후과학교실) ;
  • 이진석 (연세대학교 의과대학 이비인후과학교실) ;
  • 천제영 (연세대학교 의과대학 이비인후과학교실) ;
  • 변형권 (연세대학교 의과대학 이비인후과학교실) ;
  • 송기재 (연세대학교 의과대학 이비인후과학교실) ;
  • 김광문 (연세대학교 의과대학 이비인후과학교실)
  • Published : 2006.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

Introduction : The sensitivity of tumor cells to radiotherapy is a critical determinant of local control and potential cure in advanced head and neck squamous cell carcinoma(HNSCC). The emergence of radioresistant tumor cells is an obstacle to cancer therapy. Most radioresistant cells have a higher proportion of cells in the Sphase of the cell cycle and a lower apoptotic fraction than radiosensitive cells. HSV replication is increased in cells that have higher S-phase fractions. NV1066 is an oncolytic herpes simplex virus type-1 mutant. We hypothesized that NV1066 replication and cytotoxicity are increased in radioresistant cells. The purpose of this study is to evaluate the antitumor efficacy of NV1066 to treat radioresistant HNSCC. Methods : Radioresistant cells were selected by treating five HNSCC cell lines with repeated conventional fractionated doses of radiation(2Gy/day), using a Cs-137 irradiator, up to a cumulative dose of 70Gy. Clonogenic cell survival and S-phase fractions were compared between radioresistant and parental radiosensitive cells. The two cell populations were then treated with NV1066 to examine viral replication, by the viral plaque assay and viral cytotoxicity. Results : Fractionated irradiation resulted in the selection of radioresistant cells. Radioresistant cells had a higher S-phase fraction(42.9%) compared to parental cells(26.2%). NV1066 replication in radioresistant cells was 7.4 times higher than in parental cells(p<0.01). Treatment with NV1066 resulted in increased cytotoxicity of 24.5% in radioresistant cells compared to parental cells(p<0.05). Conclusion : NV1066 showed increased viral replication and cytotoxicity in radioresistant HNSCC cell lines. These findings suggest a potential clinical application for this oncolytic viral therapy as treatment for radioresistant head and neck cancers.

Keywords

References

  1. Brizel DM, Albers ME, Fisher SR, Scher RL, Richtsmeier JW, Hars Vl: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer N. Engl J Med. 1998;338:1798-1804 https://doi.org/10.1056/NEJM199806183382503
  2. Girinsky T, Lubin R, Pignon JP, Chavaudra N, Gazeau J, Dubray B: Predictive value of in vitro radiosensitivity parameters in head and neck cancers and cervical carcinomas: preliminary correlations with local control and overall survival. Int J Radiat Oncol Biol Phys. 1993;25:147-148 https://doi.org/10.1016/0360-3016(93)90157-Q
  3. West CM, Davidson SE, Roberts SA, Hunter RD: Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix. Br J Cancer. 1993;68:819-823 https://doi.org/10.1038/bjc.1993.434
  4. Kim SH, Carew JF, Kooby DA, et al: Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer. Cancer Gene Ther. 2000;7:1279-1285 https://doi.org/10.1038/sj.cgt.7700231
  5. Kim SH, Wong RJ, Kooby DA, et al: Combination of mutated herpes simplex virus type 1 (G207 virus ) with radiation for the treatment of squamous cell carcinoma of the head and neck. Eur J Cancer. 2005;41 (2 ):313-322 https://doi.org/10.1016/j.ejca.2004.10.018
  6. Carew JF, Kooby DA, Halterman MW, Federoff HJ, Fong Y: Selective infection and cytolysis of human head and neck squamous cell carcinoma with sparing of normal mucosa by a cytotoxic herpes simplex virus type 1 (G207 ). Hum Gene Ther. 1999;10:1599-1606 https://doi.org/10.1089/10430349950017608
  7. Wong RJ, Kim SH, Joe JK, Shah JP, Johnson PA, Fong Y: Effective treatment of head and neck squamous cell carcinoma by an oncolytic herpes simplex virus. J Am Coll Surg. 2001;193:12-21 https://doi.org/10.1016/S1072-7515(01)00866-3
  8. Wong RJ, Joe JK, Kim SH, Shah JP, Horsburgh B, Fong Y: Oncolytic herpesvirus effectively treats murine squamous cell carcinoma and spreads by natural lymphatics to treat sites of lymphatic metastases. Hum Gene Ther. 2002;13:1213-1223 https://doi.org/10.1089/104303402320138998
  9. Mineta T, Rabkin SD, Yazaki T, Hunter WD, Martuza RL: Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nature Med. 1995;1:938-943 https://doi.org/10.1038/nm0995-938
  10. Kooby DA, Carew JF, Halterman MW, et al: Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herped simplex virus type-1 (G207 ). FASEB. 1999;13:1325-1334 https://doi.org/10.1096/fasebj.13.11.1325
  11. Pearce AG, Segura TM, Rintala AC, Rintala-Maki ND, Lee H: The generation and characterization of a radiation-resistant model system to study radioresistance in human breast cancer cells. Radiate Res. 2001;156 (6 ):739-750 https://doi.org/10.1667/0033-7587(2001)156[0739:TGACOA]2.0.CO;2
  12. Lambin P, Malaise EP, Joiner MC: Might intrinsic radioresistance of human tumour cells be induced by radiation? Int J Radiat Biol. 1996;69 (3 ):279-290 https://doi.org/10.1080/095530096145832
  13. Falck J, Petrini JH, Williams BR, Lukas J, Bartek J: The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nature Gen. 2002;30:290-294 https://doi.org/10.1038/ng845
  14. Schang LM, Philips J, Schaffer PA: Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription. J Virol. 1998;72 (7 ):5626-5637